Leukocytes must traverse inflamed tissues to effectively control local infection. Although motility in dense tissues seems to be integrin independent and based on actomyosin-mediated protrusion and contraction, during inflammation, changes to the extracellular matrix (ECM) may necessitate distinct motility requirements. Indeed, we found that the interstitial motility of T cells was critically dependent on Arg-Gly-Asp (RGD)-binding integrins in the inflamed dermis. Inflammation-induced deposition of fibronectin was functionally linked to higher expression of integrin a V on effector CD4 + T cells. By intravital multiphoton imaging, we found that the motility of CD4 + T cells was dependent on a V expression. Selective blockade or knockdown of a V arrested T helper type 1 (T H 1) cells in the inflamed tissue and attenuated local effector function. Our data demonstrate context-dependent specificity of lymphocyte movement in inflamed tissues that is essential for protective immunity. A r t i c l e s npg ACKnOwLeDGMenTS We thank N. Killeen (University of California, San Francisco) for WT15 mice; R. Locksley (University of California, San Francisco) for IFN-γ reporter mice (Yeti mice); M. Nussenzweig (The Rockefeller University) for CD11c-YFP mice; R. Hynes (MIT) for Itga5 fl/fl mice; B. Leon and F. Lund (University of Alabama)
Pathogen clearance requires that effector T cells migrate into inflamed tissues and locate the infected microenvironment in the tissue. The molecular mechanisms involved in the migration of leukocytes into tissues via extravasation have been well characterized 1 . However, the interactions that control movement through peripheral tissues are less well understood.
Integrins serve a vital role in the trafficking of leukocytes from blood into tissues. Chemokine-mediated activation of integrins leads to firm adhesion of leukocytes to the endothelium, which is essential for transendothelial migration. In contrast, the interstitial migration of leukocytes is thought to be largely integrin independent 2 . Studies of the migration of cells through artificial collagen matrices or confinement chambers have suggested that the dense three-dimensional extracellular matrix (ECM) scaffold supports the use of nonadhesive, actin-based traction mechanisms by leukocytes 3, 4 . In the lymph nodes, T cells migrate along networks of fibroblastic reticular cells that express the integrin ligands ICAM-1 and VCAM-1 and the chemokines CCL19 and CCL21. However, motility is driven by chemokine-mediated chemotaxis or haptotaxis directly and does not require integrins for adhesion 5 . Similarly, genetic ablation of all known integrins in dendritic cells does not perturb the migration of such cells in the lymph nodes or skin 6 . Thus, under a variety of conditions, integrins seem to be largely dispensable for the extravascular trafficking of leukocytes.
Inflammatory mediators and pathogens themselves modify ECM density and composition in peripheral tissues, which may dictate new requirements for leukocyte motility at sites of inflammation 7 . T cells expressing distinct integrins accumulate in particular inflammatory settings and in discrete tissues in which integrin expression is thought to have a role in tissue-specific homing 8 and retention in the tissue 9 . In contrast to the environment in lymph nodes, in which collagen fibers are coated by fibroblastic reticular cells, in nonlymphoid tissues such as the skin and lungs, T cells are directly exposed to collagen fibers and associated ECM components that could act as guidance cues for movement through the interstitial space. The use of multiphoton microscopy has enabled the visualization of leukocyte motility in peripheral tissues, with studies noting a close association between T cells and matrix fibers in the skin, brain and tumors [10] [11] [12] [13] [14] [15] [16] . Lymphocyte movement in the skin during delayed-type hypersensitivity shows a correlation between collagen-binding integrins on T cells and their migration along fibers that requires calcium signaling by Kv1.3 potassium channels 14 . During infection with Toxoplasma species in the brain, effector T cells also migrate along reticular fibers, although the brain is largely devoid of infection-induced increases in collagen 13 . In many studies, blockade of signaling via G protein-coupled receptors attenuates the interstitial motility of leukocytes, but it is not clear if this is due to blockade of chemotaxis or chemokinesis itself or the absence of chemokineinduced activation of integrins. Although the interstitial migration of neutrophils in the mesentery has been shown to be integrin dependent 17 , no studies have directly assessed the role of integrins in T cell motility in inflamed peripheral tissues, to our knowledge.
A r t i c l e s Given the critical role of physical confinement in three-dimensional cell motility 4 and the extent of inflammation-driven ECM remodeling, we addressed mechanisms of the interstitial motility of effector CD4 + T lymphocytes in inflamed dermis. Inflammation was associated with a lower density of collagen fibers and with extensive deposition of fibronectin. By intravital multiphoton microscopy (IV-MPM), we found that the movement of effector CD4 + T cells in the inflamed dermis was integrin dependent and that the expression of α V integrins was essential for interstitial motility and pathogen clearance. Thus, movement through inflamed interstitial tissue requires the coordinated expression of specific integrins on effector T cells with ECM changes in the tissue.
RESULTS

Inflammation-induced migration along ECM fibers
We analyzed the interstitial migration of T cells in the inflamed and uninflamed dermis by IV-MPM. We assessed dermal location by using second-harmonic generation (SHG) to distinguish the collagen-rich dermis from the collagen-replete epidermis and from blood vessels through the intravenous injection of Texas Red-conjugated dextran ( Fig. 1a,b ). We tracked cells over time in three-dimensional space through the use of semiautomated software. We identified T cells in uninflamed dermis through the use of the progeny of mice expressing Cre recombinase driven by Cd4 (Cd4-Cre mice) crossed to mice with sequence encoding yellow fluorescent protein (YFP) knocked into the ubiquitously expressed Rosa26 locus (Gt(ROSA)26Sor tm1(EYFP)Cos mice). In these mice, YFP expression is dependent on Cre expression as a result of an upstream stop cassette flanked by loxP sites. In the steady state, 86% of YFP + cells in the dermis were αβ T cells, most of which were CD4 + and negative for the transcription factor Foxp3 ( Supplementary Fig. 1 ). In the uninflamed dermis, T cells were present at low frequencies and were uniformly non-motile ( Fig. 1c) . The average velocity of individual dermal YFP + cells (mainly αβ T cells) was 0.803 ± 0.05 µm/min (mean ± s.e.m.), which was noticeably less than that of actively surveying dermal γδ T cells in the steady state (average speed, 2-5 µm/min) 18, 19 . For T cell migration in the inflamed dermis, we monitored a population of antigen-specific CD4 + T cells. We obtained naive CD4 + T cells from WT15 mice, which have transgenic expression of a T cell antigen receptor specific for the Leishmania major peptide LACK (amino acids 156-173) 20 , and primed the cells in vitro under T helper type 1 (T H 1)-differentiation conditions. We then labeled the primed cells with the cytosolic dye CFSE and transferred them into naive BALB/c mice that we immunized in the ear dermis with cognate peptide LACK emulsified in complete Freund's adjuvant (CFA). Kinetic analysis of the inflamed dermis defined the peak of the accumulation of effector T cells in the tissue as 3-4 d after immunization (data not shown). Inflammation led to substantial changes in dermal T cell velocity ( Fig. 1c and Supplementary Movie 1), consistent with published models 14, 21, 22 . The T cells showed no 'preferential' directionality in their crawling patterns, and the mean squared displacement of their crawling tracks increased linearly over time ( Fig. 1d,e ), which suggested that these cells were not following a chemotactic gradient in the tissue. T cells crawled 'preferentially' in the lateral plane (xy) of this tissue, with limited vertical (z-axis) translocation ( Supplementary Fig. 2 ). We visualized in vivo-primed effector cells through the use of donor T cells from a reporter mouse in which YFP reports the expression of interferon-γ (IFN-γ) 23 and found that their crawling velocities and patterns were similar to those noted after the adoptive transfer of in vitro-primed effector T cells ( Fig. 1f and Supplementary Fig. 3 ). Thus, inflammation drove the recruitment and interstitial motility of effector T cells in the dermis. This enhanced T cell motility in the presence of inflammation and/or microbial stimuli was in contrast to that of dermal dendritic cells, which are motile in uninflamed dermis but immobile when exposed to microbial stimuli 24 , indicative of cell type-specific cues for motility and arrest.
Imaging showed substantial changes in the collagen fibers of the inflamed skin, as visualized by SHG ( Fig. 2a) . In contrast to the collagen structure of uninflamed skin, which was characterized by dense layers of interwoven collagen fibers, the collagen in CFA-inflamed 
npg
A r t i c l e s skin was a loose network of thick collagen bundles ( Fig. 2a-c) . The collagen fibers were also 'preferentially' oriented in the x-y plane ( Supplementary Fig. 4 ). Many T cells seemed to be crawling in directional patterns that closely followed the local collagen fibers ( Supplementary Fig. 5 and Supplementary Movie 1). To determine if there was 'preferential' migration of T cells along the matrix scaffold, we developed an unbiased quantitative technique that used computational image analysis to compare frame-by-frame directional vectors of individual T cell-migration patterns with the orientation of the matrix fibers ( Fig. 2d,e ). In this process, SHG images were converted into a map of discrete collagen fibers on the basis of local SHG intensity gradients ( Supplementary Fig. 5 ). We then compared the migratory directions of the T cells with the directions of 'local' collagen fibers (those fibers within a radius of 6 µm around the T cell centroid; Fig. 2f ) and calculated the angle differences between the vectors representing the fibers and those representing the migrating cell ( Fig. 2g ). If T cells 'preferentially' moved parallel to the local ECM fibers, we would expect more observations in close alignment (small angle differences) between ECM fibers and T cell migration than if T cell migration were random. That was indeed the result we obtained ( Fig. 2h) . We quantified the close alignment by calculating the fraction of observations with an angle difference between fiber and migrating T cell that was smaller than 15° or 30°. The fraction of closely aligned observations was significantly larger than would be expected from random T cell movement ( Fig. 2i ). We concluded that T cells 'preferentially' migrated in directions parallel to the local collagen structures, which suggested that T cells were using a form of contact guidance. These data were consistent with a haptokinetic model npg A r t i c l e s of motility, in which cells migrate along a three-dimensional surface, interacting with bound ligand through cell-surface receptors.
Integrin-dependent motility in the inflamed dermis
The density of the matrix seems to be a key determinant of the mode of interstitial motility, with integrin dependence increasing as the density of the matrix decreases 4 . Therefore, the inflammation-based changes in collagen density and the crawling pattern of T cells along the matrix fibers prompted us to revisit the integrin dependence of the interstitial migration of T cells. While imaging T cell migration in the dermis, we administered a blocking antibody to the integrin β 1 , a common receptor chain that pairs with various α-chains for binding to ECM components 25, 26 . Soon after intravenous injection of antibody to β 1 (anti-β 1 ), all intradermal T cells stopped migrating ( Fig. 3a,b ) and adopted a rounded morphology ( Supplementary Fig. 6 and Supplementary Movie 2), consistent with a loss of adhesion to the surrounding matrix. Blockade of integrin α L β 2 (LFA-1; ICAM binding) had no effect on interstitial motility (data not shown).
To confirm that β 1 was necessary for motility in the inflamed skin, we analyzed T cells genetically deficient in the β 1 subunit by studying the progeny of mice with loxP-flanked alleles encoding β 1 crossed to Cd4-Cre mice expressing the OT-II MHC class II-restricted (ovalbumin (OVA)-specific) T cell antigen receptor. The β 1 -deficient T cells showed no functional defects in clonal expansion, cytokines or tissue infiltration, as noted before 27 (data not shown). However, in contrast to results obtained by acute blockade of β 1 , we found that β 1 -deficient T cells showed no defects in migration in the dermal interstitium ( Fig. 3c,d) . The disparity in the results obtained by acute blockade and genetic deficiency raised two possibilities: that antibody treatment led to migratory arrest through activating T cell signaling or that there was genetic compensation in this model.
To assess the possible effects of anti-β 1 actively inducing signals for arrest independently of receptor-ligand blockade, we treated effector T cells with anti-β 1 and monitored migration in vitro on plates coated with integrin β 2 -dependent ICAM-1 and the chemokine CXCL12. Treatment with anti-β 1 did not lead to cell arrest ( Supplementary  Fig. 7) , which suggested that crosslinkage of β 1 was not sufficient to halt migration. In the context of redundancy and compensation, integrin β 3 seemed the likely alternative matrix-binding integrin for lymphocytes. Indeed, treatment with anti-β 3 halted migration by β 1 -deficient T cells in the inflamed dermis, which showed that β 3 was able to compensate for the genetic absence of β 1 (Fig. 3e) but not during acute blockade of β 1 (Fig. 3a,b) . Unexpectedly, treatment with anti-β 3 also led to acute migratory arrest of wild-type T cells ( Fig. 3f,g) . Therefore, both β 1 and β 3 contributed to interstitial motility, but neither was sufficient for the full migration of wild-type T cells. Consistent with the ability of both integrin β 1 and integrin β 3 to bind the Arg-Gly-Asp (RGD) sequence present in many ECM components such as fibronectin, local administration of RGD peptides led to substantial T cell migratory arrest, but local administration of control Arg-Ala-Asp (RAD) peptides did not ( Fig. 3h-j 
and Supplementary Movie 3). Thus, effector T cells required integrin-ECM interactions for T cell migration in the inflamed dermal interstitium.
Selective a V dependence for dermal motility Both β 1 and β 3 pair with the α-subunit α V , which prompted us to analyze the α-subunit use of effector T cells in the inflamed dermis. We first monitored receptor expression on a synchronous cohort of effector T cells through the adoptive transfer of naive WT15 cells, followed by immunization with LACK in CFA ( Fig. 4a) . At 5 d after cell transfer and immunization, we observed a restricted pattern of integrin expression on the effector T cells in the inflamed dermis, npg with effector T cells expressing the α 2 , α 4 and α V subunits but little α 1 and no α 5 (Fig. 4a) . To rigorously assess the role of those individual α-subunits in T cell motility, we used acute antibody blockade and IV-MPM imaging. We found a highly restricted requirement for α V in the motility of effector T cells in the inflamed dermis; blockade of α 1 , α 2 or α 4 alone or α 1 and α 2 together did not arrest T cell motility (Fig. 4b,c and Supplementary Movie 4). Thus, α V β 1 and α V β 3 seemed to be uniquely required for the interstitial motility of T cells. The finding that T cells may use both α V β 1 and α V β 3 to migrate through CFA-inflamed dermis suggested that α V expression may be limiting; that is, acute perturbations to either β-subunit diminishes the surface pool of α V integrins below a threshold needed for migration.
Fibronectin is a chief substrate for α V integrins 28 . However, dermal fibronectin was sparse in steady-state, uninflamed tissue 29, 30 (Fig. 4d) . Analysis of CFA-inflamed tissue sections showed a widespread enhancement in dermal fibronectin throughout the tissue (Fig. 4d) , consistent with published observations of humans and hamsters [29] [30] [31] . Costaining for type I and type III collagen showed that fibronectin was closely associated with the interstitial collagen fibers ( Fig. 4e and Supplementary Fig. 8) , as reported before 32 . Thus, in the inflamed dermis, substantial changes in collagen density were accompanied by a greater abundance of tissue fibronectin, consistent with a role for the RGD-dependent integrin α V in T cell motility.
Coordinate expression of integrins and ECM
We next sought to determine if expression of α V was restricted to a particular inflammation or tissue type. We found robust expression of α V in the dermis in various inflammatory settings, including a T helper type 2 (T H 2) model of atopic or allergic inflammation and infection with the protozoa L. major (Fig. 5a,b ) in both C57BL/6 (T H 1-prone) mice and BALB/c (T H 2-prone) mice (data not shown) and also after acute disruption of the skin barrier by the process of stripping with adhesive tape (Fig. 5b) . Similarly, pathogen-induced inflammation in the lungs (induced by influenza virus) and gut (induced by Heligmosomoides polygyrus) and autoimmune infiltration in the diabetic pancreas all showed uniformly high expression of α V on infiltrating CD4 + T cells. Therefore, α V expression on effector CD4 + T cells was present in various tissues and inflammation types. To identify possible context-dependent changes in integrin expression in T cells, we examined other matrix-binding α-integrin subunits. Using an unbiased hierarchical clustering analysis of the frequency of integrin-expressing T cells, we found that T cells clustered into two principal groups on the basis of tissue type (Fig. 5b) . Expression of the collagen-binding integrins α 1 and α 2 was very different between tissues: α 2 was expressed on effector CD4 + T cells in the skin under all inflammatory settings, but α 1 was not (Fig. 5b) , whereas effector T cells in the lung had high expression of both α 1 and α 2 integrins 9,33 (Fig. 5c) . T cells from the autoimmune inflamed pancreas segregated away from T cells in strong microbial-induced inflammatory settings and had low expression of both α 1 and α 2 (Fig. 5b) .
To examine the relationship between T cell matrix-binding integrins and the types of ECM components, we compared two examples of differences in integrin expression and evaluated collagen A r t i c l e s and fibronectin in the respective inflamed tissues (Fig. 5d) . As noted above, in the dermis inflamed by CFA, α V was expressed by effector T cells and was critical for motility ( Fig. 4a-c) , consistent with the colocalization of fibronectin and collagen fibers ( Figs. 4e  and 5d ). The expression of α 2 , but not α 1 , correlated with the inflammation-induced expression of collagens I and III (α 2 ligands) and the absence of inflammation-induced collagen IV (α 1 ligand) ( Supplementary Fig. 8 ). In contrast, in the lungs at day 8 after infection with influenza virus, high expression of α 1 and α 2 by effector T cells ( Fig. 5c ) was associated with large areas of the lung parenchyma dLN Ear dermis npg that were rich in collagen III (Fig. 5d, left) and extensive collagen IV around blood vessels, airways and alveoli 33 , in the absence of abundant fibronectin. The collagen III-rich areas were coincident with the leukocytic infiltrates ( Fig. 5d, far left) and were not present in uninfected lungs (data not shown). Thus, the coexpression of both α 1 and α 2 and α V integrins on effector T cells in the lungs may facilitate migration through distinct collagen-rich and fibronectin-rich regions in influenza virus-infected lungs 33 .
Upregulation of a V expression during T cell priming
The expression of α V was consistently higher on T cells in the inflamed dermis than on those in the lymph nodes ( Fig. 6a and   Supplementary Fig. 9 ). The regulation of matrix-binding integrins could occur directly in the inflamed tissue through local induction or the selection of integrin-expressing effector T cells, or it could be programmed during T cell activation in the lymph node, as reported for tissue-specific homing molecules 8, 34, 35 . To explore those possibilities, we assessed the phenotype of activated T cells in the lymph nodes and in the inflamed tissue. After intradermal immunization with LACK in CFA, antigen-specific T cells in lymph nodes segregated into three distinct populations on the basis of their expression of α V and the activation marker CD62L, with most CD62L lo cells having low expression of α V (Fig. 6a) . In contrast, effector T cells that had migrated to the dermis were predominantly α V hi CD62L lo (Fig. 6a) . 
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A r t i c l e s Cells with the highest expression of the activation markers CD25 and glycosylated CD43 in the lymph node were also mainly α V hi CD62L lo (Fig. 6b) . Blockade of egress from the lymph nodes through the use of the G protein-coupled receptor S1P 1 agonist FTY720 led to selectively more α V hi CD62L lo cells in the lymph nodes and a reciprocal loss of α V hi CD62L lo cells in the inflamed dermis ( Fig. 6c,d) . We obtained similar results for the response of polyclonal CD4 + T cells to keyhole limpet hemocyanin (KLH) in CFA and infection with L. major (Supplementary Fig. 9 ). Thus effector CD4 + T cells destined to exit the lymph node and patrol peripheral tissues had high expression of integrin α V and low expression of CD62L, consistent with 'emigrant' effector T cells 36 .
Essential role for a V in interstitial migration and effector function As noted above for T cells deleted of β 1 (Fig. 3) , T cells genetically deficient in α V (from the progeny of OT-II mice with loxP-flanked alleles encoding α v crossed to Cd4-Cre mice) remained motile in the inflamed dermis but were still susceptible to migratory arrest by RGD peptides (Fig. 7a) . Thus, there seemed to be a fundamental requirement for integrin-mediated motility in inflamed tissues, as shown by the high degree of compensation after genetic ablation. To directly assess the requirement for α V in interstitial migration, we turned to acute gene knockdown with α V -specific short hairpin RNA (shRNA). We transduced β 1 -deficient OT-II T cells (whose motility remained α V dependent; Fig. 7b ) with retrovirus expressing green fluorescent protein (GFP) alone (control vector) or retrovirus expressing GFP and α V -specific shRNA (Fig. 7c) and transferred those cells into congenic C57BL/6 mice for imaging. In our analysis of two shRNA constructs, α V -9 and α V -10 ( Supplementary Fig. 10 ), we found that knockdown of α V did not hinder the recruitment of effector T cells to the inflamed dermis ( Fig. 7d) or change the location of T cells in the tissue, as both α V -sufficient and α V -deficient effector T cells were present in the same dermal regions (Fig. 7e) . However, the stable loss of α V (Fig. 7c,f ) significantly impaired the motility of the interstitial T cells (Fig. 7g,h, Supplementary Fig. 10 and Supplementary Movie 5) . These data were notable because surface expression of α V was only ~60% lower after knockdown of α v (Fig. 7c,f) , which suggested that only a fraction of the α V surface receptors needed to be compromised to alter migration, indicative of an essential role for α V integrins in the interstitial migration of T cells in the inflamed dermis.
To determine the functional importance of α V expression, we used both gene knockdown and antibody blockade. We transduced OVA-specific β1-deficient effector T H 1 cells with control retrovirus or retrovirus expressing α V -9 shRNA and transferred those cells into congenic C57BL/6 mice immunized with OVA in CFA. T cells expressing control vector and those expressing the α V -9 shRNA homed to the inflamed dermis with a similar frequency ( Fig. 7i) and number (Fig. 7d) . To assess 'in vivo' function, we collected cells from tissues in buffer containing brefeldin A to block cytokine secretion and stained the cells intracellularly for IFN-γ, without additional in vitro stimulation 37, 38 . Knockdown of α V had no effect on the frequency of cells producing IFN-γ 'in vivo' in the draining lymph nodes (control vector, 3,500 GFP + IFN-γ-producing cells (mean); α V -9 shRNA, 3,540 GFP + IFN-γ-producing cells (mean)), which indicated that T cells in which α V was deleted were able to make IFN-γ. Nonetheless, lower α V expression by T cells led to a much lower frequency of IFN-γproducing cells in the inflamed dermal tissue (Fig. 7i) . Thus, disruption of α v -dependent interstitial motility limited the effector function of T cells (assessed here as IFN-γ production) presumably by limiting their ability to encounter antigen-bearing antigen-presenting cells in the inflamed tissue.
Clearance of L. major is critically dependent on IFN-γ-production by CD4 + T cells that have localized to the infected dermis. Therefore, to determine if the lower IFN-γ production might affect pathogen clearance, we infected wild-type mice with L. major and administered blocking antibody to α V or control antibody 4 weeks later, for a 3-week period, a time during which C57BL/6 mice mount a protective IFN-γ-dependent anti-parasite immune response. As noted with shRNA-mediated knockdown, antibody blockade of α V did not limit the generation of anti-L. major T cells in the lymph nodes (as there was a similar ratio of IL-4-producing cells to IFN-γ-producing cells for all C57BL/6 groups; data not shown) or the number of CD4 + T cells and macrophages that accumulated at the infection site ( Fig. 7j) . However, blocking α V had a significant effect on the ability to clear the pathogen, with blockade of α V leading to significantly higher parasite titers (Fig. 7k) . Such attenuated pathogen clearance would be consistent with the diminished ability of T cells to mount an efficient IFN-γ response. However, we cannot exclude the possibility of alternative mechanisms, such as an effect of the blockade of α V on the localization or function of macrophages. Our studies showed that integrin-dependent interstitial motility was essential for efficient IFN-γ-producing effector T cell function in inflamed tissues and contributed, in part, to pathogen clearance.
DISCUSSION
Here we have identified α V (with β 1 or β 3 ) as a key receptor for the intradermal motility of effector CD4 + T cells. The integrin dependence of the interstitial motility of leukocytes has been controversial, with some studies supporting a largely integrin-independent mode of migration 5, 6 . However, subsequent studies have suggested that migration modes seem to be highly dynamic, with dendritic cells transitioning seamlessly between integrin-dependent motility and integrin-independent motility 39, 40 . Thus, the requirement for integrin-driven motility is probably context dependent and influenced by inflammation-induced changes in the tissue microenvironment. We found that T cells were essentially nonmotile in uninflamed tissue but that their motility was enhanced considerably during inflammation in a manner dependent on integrins α V β 1 and/or α V β 3 . In CFAinflamed dermis, substantial structural changes in the density and composition of the tissue ECM occur, which may create an environment in which lymphocytes are dependent on integrins for motility. Integrin specificity seems to be coordinately regulated with the type of ECM changes in the inflamed tissue. Fibronectin has long been known to bind to collagen and serve as a cell adhesion substrate 32 , and we speculate that the inflammation-driven increase in fibronectin in the dermal interstitium observed across species [29] [30] [31] provides a substrate for infiltrating lymphocytes. Notably, T H 1 effector cells are unique among leukocytes in their ability to synthesize fibronectin 41 , which possibly suggests an active role for effector T cells in contributing to substrate deposition to facilitate interstitial migration. Our data have shown that upregulation of α V expression was initiated during T cell activation in the lymph node, although further selection or regulation of integrin-expressing cells may occur locally as the effector T cells enter the inflamed microenvironment. By IV-MPM, we found that α V expression was critical for the rapid amoeboid movement of effector T cells in the inflamed dermis and that perturbation of α V limited the effector function of T cells and attenuated efficient clearance of L. major.
Chemokines direct tissue-specific homing to and localization in tissues and are critical for the activation of leukocyte integrins (LFA-1 (α L β 2 ) and Mac-1 (α M β 2 )) for firm adhesion during transendothelial migration. Although this was not directly tested here, npg we speculate that integrin-dependent interstitial movement in the dermis is also contingent on chemokines for integrin activation. Indeed, many studies have shown a requirement for pertussis toxin-sensitive G protein-coupled receptors for interstitial motility. Lymphocyte crawling during transendothelial migration occurs through the dynamic assembly-disassembly of high-affinity LFA-1 in adhesive filopodia and is essential for crawling under shear flow 42, 43 . Future studies with fluorescence-tagged α V should demonstrate the dynamics of α V expression in migrating T cells in inflamed tissues. During transendothelial migration, shear forces promote migration through increased density of invasive filopodia and accelerated dissociation of LFA-1-ICAM-1 interactions 42 . The edema associated with inflammation in tissues may also result in greater 'interstitial' shear forces and thus promote integrin-dependent motility 44 . It is also possible that integrin activation could be regulated independently of chemokines, perhaps through the receptor CD44, as has been noted for transendothelial migration. Alternatively, it is possible that the dependence on integrins underlies a need to adhere to ECM fibers to contact immobilized chemokines rather than direct integrin-driven motility: disrupting integrin adhesion to ECM fibers could lead to an inability of cells to follow haptotactic gradients imposed by chemokines that coat the fibers.
Integrins serve a variety of roles in the immune response, including promoting stable T cell-dendritic cell interactions for effector function, extravasation and tissue retention or survival. Distinct integrins direct tissue-specific homing (integrin α 4 β 7 and gut accumulation) and may determine localization within the tissue, as suggested by expression of α 1 by T cells and their accumulation in the epidermis and the lung epithelium 33, 45 . Our data have shown an essential role for integrins in the movement of T cells through the inflamed tissue and suggest that specific integrin expression is dictated by the changes in ECM components. As concluded from in vitro models 2 , the density of the ECM scaffold may also influence the mode of motility, with the degree of confinement dictating the utility of nonadhesive actin-myosin-based movement versus adhesive integrin-based migration 4 . Thus, the mode of motility at sites of inflammation may differ depending on the extent of remodeling, density or composition of the ECM.
Notably, α V itself has a critical role in shaping the inflammatory microenvironment through modulating the expression of cytokines and matrix components. The binding of α V to latent transforming growth factor-β via its RGD motif leads to the release of transforming growth factor-β from the ECM and biological activation 46 that is important in wound healing and fibrotic events. Moreover, α V also modulates the induction of the differentiation of the T H 17 subset of helper T cells and regulatory T cells through changes in the function of dendritic cells [47] [48] [49] . The IL-4-and IL-13-induced matricellular protein periostin 50 binds to α V on keratinocytes to induce proinflammatory cytokines. Blockade of either periostin or α V potently suppresses allergic skin inflammation. Indeed, blockade or genetic ablation of α V (mainly in myeloid cells) can inhibit inflammation in experimental autoimmune encephalomyelitis, allergic asthma and lung scleroderma 47, 48, 51 , although it precipitates ulcerative colitis 52 . The requirement for α V in the interstitial migration of effector T cells through such inflamed sites may compound the therapeutic effects of targeting the α V pathway in inflammation. Notably, such α V -based motility is not required for gain of effector function or localization to the dermis but does limit robust execution of effector function, which suggests that attenuation of interstitial migration limits the ability of effector T cells to scan the microenvironment of the inflamed tissue in search of specific antigen-bearing antigen-presenting cells.
Acute disruption of α V through antibody blockade or shRNAmediated knockdown identified functional requirements for α V in the interstitial motility of T cells. However, those were not recapitulated by genetic ablation experiments, with α V -deficient T cells remaining highly motile through a compensatory mechanism dependent on RGD-binding integrins or other RGD-binding proteins. A similarly high degree of functional compensation for fibronectinbinding integrin subunits in genetically integrin-deficient mice has been reported for the developmental roles of the α V and α 5 integrin subunits 53, 54 and also for the β 1 and β 3 integrin subunits in integrindeficient cell lines 55 . These data therefore suggest a fundamental requirement for interactions between integrins and fibronectin (or other RGD-containing matrix proteins) during both development and the migration of T cells during inflammation.
Here we have shown that inflammation in the dermis necessitated an integrin-based mechanism for the interstitial migration of effector T cells that was critical for full effector T cell function in inflamed and infected tissue. It may be possible to predict the integrin requirements for interstitial migration in a given inflamed tissue by identifying the specific changes to the ECM landscape. Understanding the coordinated expression of leukocyte integrins and ECM substrates in inflamed tissues should provide new therapeutic strategies for inflammation-specific and/or tissue-specific mitigation of immunologically mediated tissue damage in autoimmunity and chronically inflamed pathologies.
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